AndroGel Lawsuit News: Federal Judge Dismisses Racketeering Claims Filed Against AndroGel Manufacturer, Bernstein Liebhard LLP Reports

Share Article

The Firm is evaluating potential testosterone treatment lawsuits on behalf of men who allegedly suffered heart attacks, strokes and other serious heart issues due to their use of AndroGel and other low testosterone therapies.

Free Case Review
It should be understood that the product liability litigation involving this and other testosterone lawsuits is a separate matter, and will not be impacted by the decision in this case.

As AndroGel lawsuits (http://www.testosteronelawsuitcenter.com/androgel-lawsuit/) involving heart injuries allegedly associated with the use of the low testosterone treatment continue to mount in U.S. courts, Bernstein Liebhard LLP notes that a federal judge in Illinois has dismissed a racketeering lawsuit that questioned the tactics used to market certain medications, including AndroGel. The lawsuit, which had been filed in the U.S. District Court, Northern District of Illinois under the Racketeer Influenced and Corrupt Organizations Act, had accused Abbott Laboratories and AbbVie Inc. of colluding to force health insurers to pay unnecessarily for AndroGel and the Humira arthritis drug. But in an Order dated September 25, 2014, U.S. District Judge Robert Dow wrote that plaintiffs had failed to show that the drug makers "joined together" illegally with pharmacies and intermediaries to maximize sales of the medications. (New England Carpenters Health and Welfare Fund et al v. Abbott Laboratories et al, No. 12-01662)

“Dozens of men who were allegedly harmed by AndroGel also have lawsuits pending in the Northern District of Illinois. It should be understood that the product liability litigation involving this and other testosterone lawsuits is a separate matter, and will not be impacted by the decision in this case,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating legal claims on behalf of men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems due to their use of AndroGel and other prescription testosterone medications.

Testosterone Treatment Lawsuits
According to court documents, at least 200 testosterone treatment lawsuits are now pending in the federal product liability litigation underway in Illinois, all of which allege the use of AndroGel and similar medications caused patients to experience life-threatening cardiovascular events. Among other things, plaintiffs allege that the manufacturers of low testosterone therapies failed to warn doctors and patients about their potential risks, and concealed those dangers from the public. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

Court records indicate that the litigation surrounding AndroGel and similar medications got underway shortly after the U.S. Food & Drug Administration (FDA) announced in January it was reviewing the cardiovascular risks associated with low testosterone treatments. On September 17th, a panel of FDA advisors voted 20-1 to recommend that the drugs’ labels be revised to make clear they have not been shown to lessen low libido, fatigue, muscle loss and other age-related symptoms. The advisors also voted by the same margin to recommend that the manufacturers of testosterone replacement therapies be required to conduct studies of their cardiovascular side effects. *

Men who used AndroGel or another low testosterone treatment may be entitled to compensation if they experienced serious heart problems allegedly associated with their use. To learn more about filing a testosterone lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 for a free case review.

*startribune.com/nation/275499791.html, Associated Press (via startribune.com), September 18, 2014
About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website